Overview
The workshop program will feature the latest advances in the application of MR to cancer research, with presentations from established scientists as well as new investigators leading the field.  In addition to invited scientific presentations, the program will include educational lectures, presentations of proffered papers and poster sessions.  The Negendank Memorial Lecture will be on advanced MRS methods in clinical assessment of cancer treatment.  There will also be a roundtable discussion on the prospects of molecular imaging by MR and how specific MRI/MRS can become in the detection of cancer diagnosis and treatment response in vivo.
A goal of this workshop is to continue the example set by our previous workshops of highlighting emerging young scientists, who can be too often bypassed in favor of their senior colleagues.  A further emphasis will be on participation by graduate students.
Audience Description:
The workshop is designed for basic researchers (MR and pharmaceutical scientists), post-doctoral and graduate students, clinical investigators (radiologists, oncologists, and pharmacologists), and residents and fellows, with interest in in vivo MR methodological development and applications to drug development.
It should be attractive to researchers from the level of graduate students to established investigators, and clinicians interested in new developments in cancer research and drug development.  This includes basic researchers in laboratories using in vivo MRS/MRI or other MR methods in drug development or cancer research and clinical investigators and clinicians in radiology, oncology, or pharmacology.